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Abstract: 
 
Previous research clearly indicates a linear relationship between exercise intensity and growth 
hormone (GH) release and that this relationship is influenced by sex. The present study 
examined the GH response to increasing exercise duration in young men and women. Fifteen 
healthy subjects (8 men and 7 women) completed three randomly assigned exercise sessions (30, 
60, and 120 min) at 70% of peak oxygen consumption. Blood samples were collected every 10 
min beginning 30 min before exercise, for a total of 240 min. Total integrated GH concentration 
(IGHC) increased with increasing exercise duration for men and women (601, 1,394, and 2,360 
μg/l·4 h; 659, 1,009 and 1,243 μg/l·4 h for 30, 60, and 120 min of exercise, respectively). 
Regression analysis revealed that IGHC (logarithmically transformed) was significantly 
influenced by exercise duration (logarithmically transformed) (120 min > 60 min > 30 min) and 
that a significant sex-dependent effect was present even after adjustments for fitness level and 
percent body fat (men > women). The slope of the regression line was greater for men than for 
women (1.003 vs. 0.612; P = 0.013), but the average height of the regression line was greater for 
women (7.287 vs. 6.595; P < 0.001). Although GH secretory pulse half-duration was greater in 
women (P = 0.001), and GH half-life was greater in men (P = 0.001), they were not affected by 
exercise duration. The total mass of GH secreted during exercise increased with exercise 
duration (P < 0.001) but was not affected by sex (P = 0.137). Results from the present 
investigation indicate that when exercise intensity is constant, exercise duration significantly 
increases IGHC and that this relationship is sex dependent. 
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Article: 
 
It is well established that exercise is a consistent, robust stimulator of growth hormone (GH) 
release (5, 11, 26, 43, 46). Although fitness level, age, and sex clearly influence exercise-induced 
GH secretion (17, 37, 41), exercise intensity and duration are likely to be the key factors that 
determine the magnitude of the exercise-induced GH response. 
 
At rest, women exhibit a less orderly pattern of GH secretion (25) and an approximately twofold 
higher GH amplitude and mass of GH secreted per burst, with comparable GH half-life and pulse 
frequency for men and women (34). Women and men have a similar pattern of GH response to 
exercise (26, 44), but women have been shown to attain peak GH concentrations sooner then 
men (46). When exercise duration is held constant, exercise intensity induces GH release in a 
linear dose-dependent fashion, although women had higher concentrations of GH at any given 
exercise intensity (26). Increasing GH release with increasing exercise intensity has been 
mechanistically attributed to increased mass of GH secreted per burst, with minimal changes 
observed in GH half-life (26, 42). 
 
Most studies investigating the influence of exercise duration have focused on the minimal 
exercise duration required to stimulate GH release. Results suggest a range of values, from <10 
min to >15 min of exercise being required to elicit an initial rise in GH release (8, 11, 21, 22, 24, 
29, 30, 32). The inconsistencies in the findings are probably due to differences in the exercise 
intensity employed in different studies. Only a few studies have investigated the effects of longer 
exercise durations on GH release (4, 24, 39), and only two controlled for exercise intensity 
throughout the exercise bout (4, 39). However, neither of these studies systematically examined 
the effects of exercise duration on GH release. This is particularly important given the recent 
guidelines from the Institute of Medicine suggesting that previous recommendations of 30 min of 
physical activity most days of the week may be inadequate for some individuals (3). The new 
guidelines suggest that 60 min of moderate-intensity exercise may be required by some 
individuals for weight maintenance, whereas as much as 90 min of exercise may be required for 
fat loss in overweight or obese individuals (3). Given the blunted GH response to 30 min of 
exercise in obese (20, 47) and older adults (42) and the influence of GH on postexercise fat 
oxidation (12, 27), understanding the GH response to increased exercise duration in young, 
healthy men and women is an important first step toward proper exercise prescription for 
individuals with altered GH release. 
 
In the present study, we investigated the effect of exercise duration, at a constant intensity, on 
GH secretion in young adult men and women. We hypothesized that longer exercise durations 
would result in greater GH release and that young women would have greater exercise-induced 
GH release at any given duration compared with young men. We also hypothesized that the 
increase in GH secretion would largely be due to increased mass of GH secreted per pulse. 
 
METHODS 
 
Subjects. Fifteen healthy subjects (8 men and 7 women) participated in the present investigation. 
All subjects completed a detailed medical history and provided written informed consent for 
participation in this study that was approved by the Institutional Review Board at the University 
of North Carolina at Greensboro. Subjects were nonsmokers, were not taking medications or 
hormones known to alter GH release, were habitual aerobic exercisers (>30 min/day, 3–4 
times/wk), and had completed at least 1 exercise session longer than 60 min within the last 
month. None of the women were taking oral contraceptives. Men reported training an average of 
1.9 h per day, 5.5 days per week, whereas women reported an average of 1.4 h of training per 
day, 4.7 days per week. Women were more likely to cross-train, and all of them reported 
resistance training as a part of their habitual training program. Only one man reported resistance 
training regularly, and four men reported that cycling was their only mode of exercise. Body 
weight was determined using a Detecto beam scale (Brooklyn, NY) accurate to 0.1 kg, and 
height was determined using a Seca stadiometer accurate to 0.1 cm. Body composition was 
estimated with Harpendon skinfold calipers using the standard methods outlined in the 
Anthropometric Standardization Reference Manual (14). All skinfold measures were taken in 
triplicate, and body fat percent was calculated using the Jackson-Pollock 7-site skinfold equation 
(1). We recognize that this is an estimate of body fat percent and not a criterion measure of body 
composition. 
 
V̇o2 peak assessment. Subjects completed a maximal cycle ergometer graded exercise test (Lode 
Excalibur, Seattle, WA) to determine peak oxygen consumption (V̇o2 peak). After a 2- to 3-min 
warm-up period, power output (PO) was set at 100 W for men and 50 W for women. PO 
increased 50 W every 2 min for men and 25 W every 2 min for women until volitional fatigue or 
when pedaling rate fell below 50 rpm. 
 
Metabolic measures were collected during the V̇o2 peak and constant-load exercise tests using 
standard open-circuit spirometric techniques (Vmax 229, SensorMedics, Yorba Linda, CA). 
Heart rate was determined using a Polar a5 heart rate monitor (Polar Electro, Woodbury, NY), 
and the subject was asked to give a rating of perceived exertion (RPE) at the end of each stage. 
V̇o2 peak was chosen as the highest mean 1-min V̇o2 value attained during testing. All subjects 
attained respiratory quotient values >1.0, and maximum heart rate (HR) was achieved, expressed 
as a percentage of age-predicted maximum, was >90% for men (average 96.3 ± 3.6%) and 
women (average 92.8 ± 3.5%). Submaximal PO values were calculated at 60, 65, and 70% of 
V̇o2 peak. After recovery, each subject cycled for 5 min at the PO predicted to elicit 60, 65, and 
70% V̇o2 peak. This step was completed to ensure that oxygen consumption (V̇o2) values would be 
within the proper range for the constant-load exercise session. 
 
Constant-load exercise. The constant-load exercise sessions consisted of randomly assigned 
cycling sessions at 70% of V̇o2 peak for 30, 60, or 120 min. At least 48 h of rest were required 
between submaximal constant-load sessions; all sessions were completed in the morning (0600–
0800 start time), after an overnight fast; and women were tested in the early follicular phase of 
the menstrual cycle (days 1–8, requiring 2–3 menstrual cycles for completion of all 3 exercise 
sessions). There was <30-min variation in the start time for the three exercise sessions for a 
given subject. After arriving at the laboratory, subjects were weighed and then rested in a supine 
position for ∼5 min. A venous cannula was placed in an antecubital vein, and resting blood 
samples were taken. Blood samples were taken every 10 min throughout the 240-min session. 
After 30 min of rest, subjects moved to the cycle and warmed up at 50% of V̇o2 peak and slowly 
increased to 70% of V̇o2 peak by 5 min. Subjects then completed 30, 60, or 120 min of exercise at 
70% V̇o2 peak, followed by a 1-min cool-down at 50% V̇o2 peak. During exercise, V̇o2 was 
measured by breath-by-breath analysis and was recorded as 1-min averages. At 15-min intervals, 
V̇o2 measures were assessed, and PO was adjusted to maintain exercise intensity at 70% V̇o2 peak. 
When necessary, PO was reduced so that subjects could complete the entire exercise duration. 
HR was monitored continuously using a Polar HR monitor, and RPE was recorded at 15 min 
intervals. Average HR and RPE were calculated for each exercise session. At the completion of 
exercise, subjects rested quietly in the laboratory while blood sampling continued. Total work, 
end-exercise V̇o2 (over last 5 min), and total caloric expenditure were calculated for each trial. 
Total caloric expenditure was calculated as follows: kilocalories = total V̇o2 (liters) × 5. 
 
Assays. All samples were collected in red-top vacutainers and allowed to clot at room 
temperature for 30 min. Samples were centrifuged at 1,500 g for 15 min, separated into multiple 
aliquots, and stored at −80°C. At the conclusion of the study, samples were shipped to the Core 
Laboratory facilities at the General Clinical Research Center at the University of Virginia for 
measurement of GH. GH concentrations in serum samples were measured using a validated 
ultrasensitive (0.005 μg/l threshold) chemiluminescence-based assay (Nichols, San Juan 
Capistrano, CA) (6, 18). The chemiluminescent assay detects predominantly the 22-kDa form of 
GH and has a cross-reactivity level of 34% for 20-kDa GH (methionylated). The intra-assay 
coefficient of variation (CV) for the GH assay was 6.0%, and the interassay CV was 9.9%. 
Estradiol was measured using an enzyme immunoassay from DSL (DSL-10-4300, Webster, TX), 
and all samples were measured in a single assay. Intra-assay CV for the estradiol assay was 
7.4%. 
 
Deconvolution analysis. A multiple-parameter deconvolution method was used to estimate 
pulsatile attributes of GH secretion from the measured serum GH concentrations (19). A pulse of 
underlying GH secretion was approximated algebraically by a Gaussian distribution (35). Basal 
secretion was estimated concurrently with a subject-specific two-component half-life for 
endogenous GH. The first component of the half-life was fixed at 3.5 min, and the second 
component was subject specific. Deconvolution was performed as outlined previously (45), and 
overdetermination of GH pulses was avoided by eliminating any successive GH pulses that were 
separated by less than two sampling intervals (20 min). In addition, any pulses outside the 
sampling window (0–240 min) by more than one sampling interval (10 min) were eliminated. 
Integrated GH concentration (IGHC) was calculated using trapezoidal integration. Total mass of 
GH secreted during exercise was calculated as the sum of GH area under all pulses during 30, 
60, and 120 min of exercise, and GH production rate was calculated by multiplying the number 
of GH pulses by GH mass per pulse. Mean GH concentration was calculated for exercise plus the 
first 60 min of recovery (time used for determining the average was 90, 120, and 180 min, 
respectively, for the 3 sessions). 
 
Statistical analysis. All data were analyzed by way of parametric statistical methods. 
Specifically, the deconvolution data and the constant-load exercise data were analyzed by way of 
mixed-effects repeated-measures ANOVA. Data for IGHC were also analyzed by way of random 
coefficient regression. The baseline data were analyzed by way of one-way ANOVA. 
 
The model specification for the ANOVA included two categorical variables, sex and exercise 
duration (30, 60, and 120 min). Sex by exercise duration interaction was also modeled. Because 
of the repeated-measures design, the variance-covariance matrix of the ANOVA was modeled in 
the spatial power form, a form that is appropriate for unequally space repeated measures. 
 
Linear contrasts of the mean response were used to test our a priori hypotheses. All of the 
statistical tests were two sided with the alpha level of the test set at 0.05. The multiple 
comparison type I error rate adjustment was based on Fisher’s restricted least significant 
difference criterion. 
 
The specification of the random coefficient regression model for the analysis of IGHC included 
one categorical variable (sex) and three continuous variables (percent body fat, exercise duration, 
and V̇o2 peak). The variance-covariance matrix was model in the spatial power form. Confidence 
intervals for the regression coefficients were constructed based on the t-statistic multiplier. The 
Working-Hotelling multiplier was used to construct the simultaneous confidence bands for 
estimating the population mean profile for log e (IGHC) as a function of log e (exercise duration) 
after adjustment for percent body fat and V̇o2 peak. 
 
The ANOVA models for analyzing the subjects’ baseline characteristics included a single 
categorical variable, the sex of the subject. All of the hypothesis tests from the ANOVA were 
two-sided with the alpha level of the test set at 0.05. 
 
Several of the response variables were statistically analyzed on the natural logarithmic scale. 
This scale transformation was carried out when residual diagnostics indicated that the data were 
log-normally distributed. For these variables, the ANOVA estimates for the difference between 
the least squares means were exponentiated so that the comparison could be presented in the 
form of a ratio of the geometric means. The geometric mean is a location parameter similar to the 
arithmetic mean and median, and the ratio of geometric means is often referred to as a fold 
change in the response. 
 
The PROC MIXED procedure of SAS version 9.1 (SAS Institute, Cary, NC) was used to conduct 
all of the statistical analyses. 
 
RESULTS 
 
Subject characteristics are shown in Table 1. Men were significantly taller (P = 0.004), were 
more fit (P < 0.001), and had less body fat (P = 0.008) than women, but men and women were 
similar in age and weight. 
 
Table 1. Subject characteristics for men and women 
 
 
Table 2 reports total work completed, calories expended, mean end-exercise V̇o2, average HR, 
average RPE, and end-exercise V̇o2 expressed as a percentage of V̇o2 peak (%EE/V̇o2 peak) for men 
and women for each exercise duration. As expected, total work and kilocalories increased 
significantly with exercise duration (P = 0.005). Average HR was similar for men and women 
(P = 0.186) and for each exercise trial (P = 0.876), despite differences in PO. Average RPE was 
similar for men and women (P = 0.35) and increased with longer exercise duration (P = 0.003). 
Both sex (P < 0.001) and exercise duration (P = 0.001) significantly influenced total kilocalories 
and end-exercise V̇o2 values. As expected, men had higher absolute end-exercise V̇o2 values than 
women (P < 0.001). End-exercise V̇o2 was lower at the end of 120 min of exercise than at the 
end of the 30- and 60-min exercise sessions for both men and women (P < 0.001). All subjects 
required a reduction in PO to complete the 120-min exercise session. When decreases in PO 
were expressed as a percentage of the initial PO, the drop was 34.8 ± 12.9% for men and 36.4 ± 
4.6% for women (P = 0.77) and when end-exercise V̇o2 was expressed as a percentage of V̇o2 
peak, exercise duration affected %EE/V̇o2 peak (P = 0.001). A significant reduction in the %EE/V̇o2 
peak was observed during 120 min of exercise (P < 0.001), with no significant sex differences in 
exercise time completed before the reduction in PO (34.8 ± 14.3 min for men and 27.4 ± 10.7 
min for women; P = 0.139). 
 
Table 2. Sex comparisons for the constant-load aerobic exercise sessions 
 
 
Figure 1 shows the mean serum GH concentrations from blood sampled at 10-min intervals over 
4 h for the three exercise conditions in women (A) and men (B). The peak serum GH 
concentrations for women were 10 ± 1.1, 13 ± 1.5, and 14 ± 1.4 μg/l for 30, 60 and 120 min of 
exercise, respectively. The corresponding values in men were 13 ± 1.3, 22 ± 5.4, and 24 ± 5.3 
μg/l. Peak GH attained was significantly influenced by both exercise duration (60 min and 120 
min > 30 min; P = 0.003) and sex (men > women; P = 0.039). Time to reach peak GH 
concentration, measured from the onset of exercise, was similar for men and women for the 30-
min exercise session (32.5 ± 1.6 and 32.9 ± 3.6 min, respectively). Time to reach peak GH 
concentration for 60 and 120 min of exercise was 37.1 ± 4.7 and 38.6 ± 4.6 min for women and 
50.0 ± 4.2 and 53.8 ± 7.8 min for men, but this difference did not attain statistical significance 
(P = 0.094). Time to reach peak GH concentration was significantly influenced by exercise 
duration, with the times for 60 and 120 min being greater than for 30 min (P = 0.003). 
 
Total IGHC over 4 h increased in an exercise duration-dependent manner (601 ± 65.4, 1,394 ± 
312.3 and 2,360 ± 480.0 μg/l·4 h in men and 659 ± 89.0, 1,009 ± 139.1 and 1,243 ± 139.1 μg/l·4 
h in women for exercise durations of 30, 60, and 120 min, respectively). IGHC was significantly 
influenced by exercise duration (120 min > 60 min > 30 min) (P < 0.001), but it was not 
influenced by sex (P = 0.21). However, there was a trend for a sex × exercise duration 
interaction on IGHC (P = 0.059). A similar response pattern was observed for mean GH 
concentration calculated for exercise plus the first 60 min of recovery (Table 3). Mean GH 
concentration was significantly influenced by exercise duration (120 min > 60 min > 30 min) 
(P < 0.001) but not by sex (P = 0.10). As observed with IGHC, there was a trend for a sex by 
exercise duration interaction with mean GH concentration (P = 0.068). 
 
 
Fig. 1. Serum growth hormone response profiles for women (A) and men (B) for 30, 60, and 120 
min of exercise. Values are means ± SD. 
 
Table 3. Effects of increasing exercise duration on measures of GH secretion during 4 h of blood 
sampling in young men and women as determined by deconvolution analysis 
 
 
Figure 2 depicts the regression of log (IGHC) and log (exercise duration) for men and women. 
Because there were significant sex differences in fitness level and percent body fat and because 
these markers have been shown to alter GH production, we included the factors in the random 
coefficient regression model. When log (exercise duration) was used as the primary variable of 
interest, the P values for the tests of interaction of sex with fitness level and sex with percent 
body fat were not significant (P = 0.428 and P = 0.579, respectively). Thus, although fitness 
level and percent body fat influence GH production, the influence was approximately equal in 
men and women and these factors were given equal weighting in the regression equations, 
regardless of sex. However, even after these adjustments, the regression of log (IGHC) and log 
(exercise duration) was significantly influenced by sex (P = 0.013). The slope of the regression 
line was greater for the men than for the women {1.003 [95% confidence interval (CI) (0.794, 
1.212)] vs. 0.612 [95% CI (0.356, 0.868)]; P = 0.013}, but the average height of the regression 
line was greater for women than for men {7.287 [95% CI (6.950, 7.624)] vs. 6.595 [95% CI 
(6.291, 6.899)]; P < 0.001}. 
 
 
Fig. 2. Regression for log [(IGHC)] with log (exercise time) for women (A) and men (B). Slope 
and 95% confidence intervals (dotted lines) are given as log values. Equation for the relationship 
in women is log e (integrated GH concentration) = log e4.086(time)·0.612(peak oxygen 
consumption)·0.731(%fat)−0.722 and for men is log e (integrated GH concentration) = 
log e1.796(time)·1.003(peak oxygen consumption)·0.731(%fat)−0.722. 
 
Table 3 presents the deconvolution results for men and women for each of the exercise bouts. 
GH secretory pulse half-duration and GH half-life were significantly influenced by sex (P = 
0.001 and P = 0.001, respectively), but they were not changed by exercise duration. GH 
secretory pulse half-duration was greater in women than in men (P = 0.001), whereas GH half-
life was consistently greater for men than women (P = 0.001). The total mass of GH secreted and 
GH production rate were influenced by exercise duration (P < 0.001 for both), but they were not 
influenced by sex (P = 0.238 and P = 0.63). Production rate of GH during 60 and 120 min of 
exercise was similar, but it was greater than the GH production during 30 min of exercise. A 
similar pattern was observed for total mass of GH secreted. Men had more GH pulses than 
women during 60 and 120 min of exercise, but men had significantly fewer GH pulses during the 
shortest exercise trial (30 min; P = 0.004). The GH mass secreted per burst was not influenced 
by sex (P = 0.36) or exercise duration (P = 0.40). 
 
Estrodiol (E2) levels were measured in each woman at baseline for each exercise session and did 
not significantly differ across trials (P = 0.45) (average E2 was 93.0 ± 11.0, 105.2 ± 14.8, and 
82.7 ± 9.3 pg/ml for the 30-, 60-, and 120-min exercise sessions, respectively). 
 
DISCUSSION 
 
The major findings of the present investigation indicate that in young men and women when 
exercise intensity is controlled, the relationship between IGHC and exercise duration 
(logarithmically transformed) is linear (up to 120 min of exercise) and sex dependent even after 
controlling for fitness and percent body fat. 
 
To our knowledge, this is the first study to systematically compare the influence of exercise 
duration on GH secretion in young men and women. Previous studies observed a continual 
increase in GH concentration until ∼60 min of exercise (4, 24, 39), but only one study completed 
an exercise session longer than 60 min. Viru et al. (39) reported a nonsignificant drop in GH 
concentrations from 60 to 120 min, but no information about the pattern of GH release was 
available, because GH samples were taken only at 60 and 120 min of exercise. Frequent 
sampling during exercise in the present study confirms steady increases in GH concentration 
until 60 min of exercise was completed (90 min into the protocol); continued exercise resulted in 
a plateau or slight decline in GH in both men and women. This corroborates previous research 
indicating that the pattern of exercise-induced GH secretion is independent of sex (4, 5, 26, 42, 
43, 46), despite well-documented sex-dependent differences in GH secretion at rest (9, 13, 15, 
25, 31, 33, 46) and large interindividual variability in GH (10, 11, 43). 
 
Our regression analysis revealed that when log transformed, the slope of the regression line for 
IGHC and exercise duration was greater for men compared with women. This is antipodal to our 
original hypothesis that women would have greater GH release at any given exercise duration. 
Because the women in the present study were less fit and had greater percent body fat than the 
men and previous research has shown that body fat and fitness level alter GH release (7, 37, 41), 
we investigated whether or not body fat and fitness level were the primary cause of the sex-
dependent differences in the slope of the regression line. Further analysis revealed that even after 
adjustments for fitness and body fat, there was a sex-specific influence on the regression of log 
(IGHC) and log (exercise duration) (P = 0.013), with men having a greater slope than women. 
These analyses clearly show that other sex-dependent factors are important for determining the 
exercise-induced GH response when exercise duration is increased in a systematic fashion. 
 
Previous research indicates that submaximal aerobic exercise-induced GH release may not 
adhere to the normal autofeedback pattern and may partially “break through” GH autofeedback 
(21, 38). Veldhuis et al. (38) reported that despite significant negative feedback during exercise, 
marked stimulation of GH secretion still occurred with exercise in both women and men, 
indicating that feedback resistance with exercise is partial, not complete. Only two studies have 
directly compared the sensitivity of the GH autofeedback system in men and women (36, 38). 
When pharmacological concentrations of GH (>100 ng/ml) were used, women had markedly 
greater fractional feedback inhibition of pulsatile GH secretion at rest. Although suppression of 
exercise-induced GH secretion was significant and equivalent in both men and women, it was 
only partial (38). When physiological concentrations of GH were used at rest, the extent of 
suppression of GH secretory-burst mass was less in young women than in men, but this study did 
not include an exercise stimulus (36). Studies employing recombinant human GH infusions to 
investigate GH autofeedback have consistently reported decreases in GH secretion within 120 
min of infusion (2, 28, 36, 38). This could suggest that during prolonged exercise, the declining 
GH secretion may be partially related to autofeedback. As suggested by Veldhuis et al., this 
feedback inhibition is only partial, because GH pulses continued to be observed throughout the 
entire 120 min of exercise in both men and women, indicating continued stimulation of GH 
secretion despite significantly elevated circulating GH. Compared with women, men had greater 
peak GH concentrations, greater mean GH concentrations (calculated for exercise plus the first 
60 min of recovery), and greater IGHC with the longer exercise durations (60 and 120 min), with 
minimal sex differences observed during 30 min of exercise. It is possible that during longer 
durations of exercise, women may be more sensitive to fractional feedback inhibition from GH 
secretion than men, regardless of the GH concentration attained. 
 
Increasing exercise intensity results in a sex-dependent, positive linear increase in GH release, 
with young women exhibiting greater GH release compared with young men at all exercise 
intensities and increased GH secretion mechanistically attributable to increased mass of GH 
secreted per burst (26, 42). In contrast, systematic increases in exercise duration resulted in 
significantly greater GH secretion in young men compared with young women (slope = 1.003 vs. 
0.612, for men and women). Mechanistically, the increase in GH secretion appears to be largely 
related to an increased number of GH pulses with increasing exercise duration in men. This 
contradicts our original hypothesis that increases in GH secretion would be mechanistically due 
to increased mass of GH per burst. In women, a combination of changes occurred that resulted in 
increased GH secretion with increasing exercise intensity, but pulse number did not increase as 
significantly as it did for men. This corroborates our suggestion that during longer durations of 
exercise, women may experience greater fractional feedback inhibition of GH secretion then 
men. 
 
During exercise, peripheral markers of heightened adrenergic outflow (epinephrine and 
norepinephrine) have been shown to be correlated to exercise-intensity-dependent GH release 
and thus implicated as a possible moderator of exercise-induced GH release (40). Horton et al. 
(16) reported that during 120 min of exercise at 40% of maximal V̇o2, epinephrine and 
norepinephrine were significantly greater in men than women. Stimulation of α2-adrenoreceptors 
with an agonist such as clonidine results in GH release by decreasing somatostatin release and 
increasing GH-releasing hormone release, and this α2-adrenoreceptor mediated GH release is 
significantly higher in young men than young women (23). Although we did not measure 
peripheral catecholamine concentrations in the present study, it is possible that higher exercise-
induced GH concentrations observed in men with increasing duration of exercise may be 
partially due to sex-dependent differences in exercise-induced catecholamine release. 
 
Because of the slow component of V̇o2 (e.g., oxygen drift) associated with higher exercise 
intensities, reductions in PO were necessary for all subjects to maintain exercise intensity at 70% 
V̇o2 peak throughout exercise. Average HR was similar for all the exercise sessions, which 
suggests that even when V̇o2 was slightly below the intended intensity, the stress on the 
cardiovascular system was similar. Average RPE data also suggest that despite drops in PO, 
subjects perceived the work to be hardest in the 120-min exercise session. Although total work 
completed and %EE/V̇o2 peak were not influenced by sex (P = 0.094 and P = 0.272, respectively), 
men did maintain a slightly higher intensity at the end of the 120-min bout of exercise. 
Therefore, given the influence of exercise intensity in determining GH secretion (26, 42), we 
cannot completely negate this nonsignificant difference as a partial mediator of GH secretion in 
the present study. Also, it is possible that because women were more likely to cross-train then 
men and were less likely to cycle exclusively as their mode of exercise, we did not obtain a true 
V̇o2 peak for the women in the study. When we investigated this possibility we found that women 
were just as likely to meet the criteria for achieving V̇o2 peak as men. Thus, although we 
acknowledge that we may not have achieved a true V̇o2 peak for all subjects, the issue does not 
appear to be sex specific. 
 
In summary, it appears that both intensity and duration of exercise are important modulators for 
determining the magnitude of the exercise-induced GH response, but the overall importance of 
either factor may be influenced by the sex of the individual performing the exercise. These 
results have implications for exercise prescription because intensity of exercise appears to be 
more influential in determining the magnitude of the exercise-induced GH response in young 
women, whereas exercise duration appears more influential in young men. If current physical 
activity recommendations for weight loss favor longer durations of exercise (60–90 min), then 
consideration must be given to how this influences the hormonal and metabolic responses. This 
is particularly important because previous research indicates that the postexercise fat oxidation 
rate is directly related to GH release (12, 27). Thus the optimal combination of exercise intensity 
and duration that will increase the GH response to exercise may be particularly critical for older 
and obese adults in whom the GH response to exercise is impaired (20, 42). 
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